Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where R. Zittoun is active.

Publication


Featured researches published by R. Zittoun.


Infection Control and Hospital Epidemiology | 1999

Efficacy of Prevention by High-Efficiency Particulate Air Filtration or Laminar Airflow Against Aspergillus Airborne Contamination During Hospital Renovation

Muriel Cornet; Vincent Levy; Laurent Fleury; Jacques Lortholary; Sandrine Barquins; Marie-Hélène Coureul; Elisabeth Deliere; R. Zittoun; Gilles Brücker; Anne Bouvet

OBJECTIVEnTo evaluate efficacy of laminar airflow facilities plus high-efficiency particulate air (HEPA) filtration and HEPA filtration alone in preventing environmental Aspergillus contamination during hospital renovation. To show the usefulness of environmental surveillance to facilitate protection of patients at risk for invasive pulmonary aspergillosis.nnnDESIGNnProspective sampling of air and surfaces for Aspergillus conidia during 2-year period.nnnSETTINGnA hematological department adjacent to building renovation at a university hospital.nnnRESULTSn1,047 air samples and 1,178 surface samples were collected from January 1996 to December 1997. Significantly more air samples were positive for Aspergillus species during the period of building renovation than during the periods before and after renovation in a unit without a protected air supply adjacent to the building work area (51.5% vs 31.7%; odds ratio [OR], 2.3; 95% confidence interval [CI95], 1.4-3.7; P<.001). A major increase in the frequency of positive air samples was also found in another adjacent unit that was protected with HEPA filtration alone (from 1.8% to 47.5%; OR, 48.9; CI95, 12-229; P<10(-7)). In addition, in this unit, the mean count of Aspergillus conidia in positive air samples increased significantly during construction (4 colony-forming units [CFU]/m3 to 24.7 CFU/m3; P=.04) and the proportion of positive surface samples showed a significant increase during renovation (from 0.4% to 9.7%; OR, 28.3; CI95, 3.4-623; P=10(-4)). However, none of 142 air samples collected during renovation in the area protected with laminar airflow plus HEPA filtration showed Aspergillus conidia. In a unit distant from the building renovation site, the results of air and surface samples were not affected by renovation.nnnCONCLUSIONnThis study showed a strong association between building renovation and an increase in environmental Aspergillus contamination. Results confirmed the high efficacy of laminar airflow plus HEPA filtration and a high air-change rate. Although filtration with HEPA was effective during normal conditions, it alone was unable to prevent the rise of Aspergillus contamination related to building renovation. This study emphasized the necessity of an environmental survey of airborne contamination related to construction, to facilitate prevention of nosocomial aspergillosis outbreaks. A standardized protocol for aerobiological surveillance is needed.


American Journal of Hematology | 1996

Treatment of agnogenic myeloid metaplasia with danazol: A report of four cases

Vincent Levy; A. Bourgarit; Alain Delmer; Ollivier Legrand; M. Baudard; Bernard Rio; R. Zittoun

Peripheral cytopenias are common in patients with agnogenic myeloid metaplasia (AMM). They are an important cause of morbidity and mortality, and their treatment is difficult. We report on 4 patients with AMM and severe cytopenia treated with danazol (400–600 mg/day). Three of them became independent of red blood cell (RBC) transfusion, while the other had a slight reduction in RBC requirement. In addition, correction of thrombocytopenia and disappearance of splenomegaly were observed in 1 and 2 patients, respectively. No side effects were observed. In our experience, danazol appears effective and safe in the subset of patients with AMM whose disease is mainly characterized by bone‐marrow failure. These data warrant further studies to evaluate this treatment and explore its mechanism of action.


Bone Marrow Transplantation | 1997

Disseminated superficial porokeratosis after autologous bone marrow transplantation

Bernard Rio; C Magana; A Le Tourneau; Claude Bachmeyer; V Lévy; N Hamont; J. Diebold; R. Zittoun

A case of disseminated superficial porokeratosis (DSP) is reported in a black man 5 years after autologous bone marrow transplantation (BMT) for acute promyelocytic leukemia. Porokeratosis is a rare hyperkeratotic disorder arising from clonal keratinocytes with a high potential to develop squamous cell carcinoma. Inherited forms are classical but recent observations of acquired porokeratosis have been reported in immunocompromized patients (AIDS, immune disorders, immune suppressive drugs or organ transplantation). Two cases of DSP have been reported after allogeneic BMT in patients treated for chronic GVHD. Our case is the first one after autologous BMT, in a black man, on no immunosuppressive drug at the time of diagnosis of DSP. Hematopoietic and immune reconstitution was apparently complete. The cancer-prone character of porokeratosis could be favored by total body irradiation used in conditioning regimen. Thus, porokeratosis has to be associated with other late effects after BMT such as HCV seropositivity, cataract and infertility that were observed in this patient.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 1997

Sphenoid sinus localization of multiple myeloma revealing evolution from benign gammopathy

Claude Bachmeyer; Vincent Levy; Martine Carteret; Olivier Laccourreye; Claire Danel; Agnès Le Tourneau; R. Zittoun; Gilles Grateau

Plasma‐cell neoplasms of the head and neck include extramedullary plasmacytoma and solitary plasmocytoma of bone or may represent a local manifestation of multiple myeloma. Involvement of sphenoid sinus has been rarely reported in multiple myeloma.


Pathology Research and Practice | 1988

Angio-Immunoblastic Lymphadenopathy (AIL) or T-cell Malignant Lymphoma of AIL-Type: A Histopathological, Immunohistochemical and Ultrastructural Study of 8 Cases

S. Caulet; Josée Audouin; A. Le Tourneau; J. Diebold; A. Bernardou; R. Zittoun

Eight cases of AIL-type T-cell malignant lymphoma are reported. The clinical symptoms are the same as those described in AIL: fever, malaise, weight loss, skin rashes, polyadenopathy, and splenomegaly. However, some differences can be noted: the absence of hepatomegaly in all cases but one, the absence of polyclonal hypergammapathy in all cases but one, and predominance in females. The lymph node modifications comprise diffuse infiltrations of lymphoid cells with irregular nuclei and pale cytoplasm, associated with a large number of immunoblasts and plasma cells. Some eosinophilic granulocytes and epithelioid cells can be seen. Hyperplasia of the vessels and remnants of follicles, sometimes with proliferation of follicular dendritic cells, are prominent features. The immunolabelling study demonstrates the presence of an important T-cell population all expressing a high predominance of CD 4 phenotype. These findings are in accordance with those published in Europe and in contrast with those of some of the Japanese cases, particularly the first patients published by Shimoyama et al. The differential diagnosis with AIL is based on the presence of clusters of mainly large cells with a pale cytoplasm, on the loss of expression of one T cell marker, as in 3 cases of our series, and on the presence of a high percentage of lymphoid cells engaged in the mitotic cycle as demonstrated with the Ki 67 monoclonal antibody. However, to draw a clear cut difference between AIL-type T-cell lymphoma and AIL considered as a prelymphomatous dysimmune lymphadenopathy, only the demonstration of cytogenetic abnormalities, as in one of our cases or of rearrangement of the genes coding for beta and/or gamma chain of the antigen receptor of T-cell are valuable criteria. The follow-up of our series is not long enough to appreciate the prognosis. Three patients died, one from a glioma. All the other cases, treated with polychemotherapy show total remission with an evolution of 10 to 39 months.


Acta Haematologica | 1992

Primary Adrenal Lymphoma

F. Bauduer; Alain Delmer; A. Le Tourneau; C. Guettier; J. H. Alexandre; R. Zittoun; Alain Bernadou


American Journal of Hematology | 1997

Specific cutaneous involvement indicating relapse of Burkitt's lymphoma

Claude Bachmeyer; Ali Bazarbachi; B. Rio; A. Delmer; M. Hunault; R. Zittoun; A. Le Tourneau; S. Aractingi


Hematological Oncology | 2006

Histopathological study of bone marrow biopsies in 30 cases of T-cell lymphoma with clinical, biological and survival correlations

S. Caulet; Alain Delmer; Josée Audouin; A. Le Tourneau; Alain Bernadou; R. Zittoun; J. Diebold


American Journal of Hematology | 1996

Two cases of epidemic mucormycosis infection in patients with acute lymphoblastic leukemia.

Vincent Levy; B. Rio; Ali Bazarbachi; M. Hunault; Alain Delmer; R. Zittoun; V. Blanc; M. Wolff


Leukemia Research | 2000

Incidence of haematological malignancies in French Polynesia between 1990 and 1995: Leukemia Research 23 (1999), 349–355

Laurent Roda; F. de Vathaire; Bernard Rio; A. Le Tourneau; P. Petididier; François Laudon; R. Zittoun

Collaboration


Dive into the R. Zittoun's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

J. Diebold

Paris Descartes University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bernard Rio

Paris Descartes University

View shared research outputs
Top Co-Authors

Avatar

Josée Audouin

Paris Descartes University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

B. Rio

Hotel Dieu Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ali Bazarbachi

American University of Beirut

View shared research outputs
Researchain Logo
Decentralizing Knowledge